These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 19722781

  • 1. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
    Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J, ENIA Study Group.
    Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
    [Abstract] [Full Text] [Related]

  • 2. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 3. Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
    Ihbe-Heffinger A, Paessens BJ, von Schilling C, Shlaen M, Gottschalk N, Berger K, Bernard R, Kiechle M, Peschel C, Jacobs VR.
    Onkologie; 2011 Mar; 34(5):241-6. PubMed ID: 21577029
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of direct medical costs of hospitalization for febrile neutropenia.
    Lathia N, Mittmann N, DeAngelis C, Knowles S, Cheung M, Piliotis E, Shear N, Walker S.
    Cancer; 2010 Feb 01; 116(3):742-8. PubMed ID: 20029970
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer.
    Timmer-Bonte JN, Adang EM, Smit HJ, Biesma B, Wilschut FA, Bootsma GP, de Boo TM, Tjan-Heijnen VC.
    J Clin Oncol; 2006 Jul 01; 24(19):2991-7. PubMed ID: 16682725
    [Abstract] [Full Text] [Related]

  • 6. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
    Timmer-Bonte JN, Adang EM, Termeer E, Severens JL, Tjan-Heijnen VC.
    J Clin Oncol; 2008 Jan 10; 26(2):290-6. PubMed ID: 18182670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
    Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.
    Cancer; 2006 May 15; 106(10):2258-66. PubMed ID: 16575919
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
    Tuffaha HW, Treish IM, Zaru L.
    J Oncol Pharm Pract; 2008 Sep 15; 14(3):131-8. PubMed ID: 18524866
    [Abstract] [Full Text] [Related]

  • 14. Granulocytic growth factors and cancer-related neutropenia: limited effects.
    Prescrire Int; 2006 Oct 15; 15(85):189-91. PubMed ID: 17128529
    [Abstract] [Full Text] [Related]

  • 15. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
    McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A.
    Gynecol Oncol; 1996 Aug 15; 62(2):247-53. PubMed ID: 8751557
    [Abstract] [Full Text] [Related]

  • 16. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW, Sung HJ, Park KH, Yoon SY, Kim SJ, Oh SC, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS.
    Am J Hematol; 2003 Aug 15; 73(4):263-6. PubMed ID: 12879430
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.